[ad_1]
A recent scientific study, conducted by Irish researchers, found that the breast cancer drug, which is taken by thousands of women, increases the risk of developing uterine cancer. According to the site of the "seventh day".
According to the website of the British "Daily Mail" newspaper, the Irish study concluded that taking tamoxifen for 10 years increases the risk of endometrial cancer by 1.5% to 3.5 %. [Olderresearchessuggestthatamoxifeninhibitsthehormoneestrogentostimulatethegrowthofcancerintheuseofadministrativeprocessorpresendentialtreatmentforindividualswithstrongfamilyhistoryofthedisease
Although the drug prevents the hormone estrogen in the breast tissue, it acts as a uterine hormone, increasing the risk of endometrial cancer in users.
According to the American Cancer Collection causes endometrial cancer to tamoxifen in about one in every 500 women.
The findings were recently published in the British Journal of Surgery
[ad_2]
Source link
